Treatment sequencing and ongoing clinical trials in anemic myelofibrosis [Video]

During the Clinical Trial Club live webinar, “Treatment sequencing for anemic myelofibrosis,” myeloproliferative neoplasms expert, Angela Fleischman, discussed optimal treatment sequencing in anemic myelofibrosis, as well as reviewing key data from recent clinical trials investigating luspatercept and pacritinib. This video captures some of the highlights from her presentation, while the full video is available here.